Our Portfolio

Ambry Genetics Corporation

Outline Genetic testing services for breast cancer, colon cancer, and other diseases
Website

http://www.ambrygen.com/

Industry Health/medicine
Commercialization stage Utilization of overseas management resources

Provided Support

  • Promote commercialization of unique technology from Japan and expansion of overseas business by combining Konica Minolta’s protein-sensitive quantitative detection technology with Ambry’s genetic diagnostic technology
  • Establish genetic testing business to contribute to the promotion of precision medicine in Japan
Authorized Investment USD 400M (maximum)
Announcement Date Jul 06, 2017
Investment Structure

Related Press Releases

Jul 06, 2017
Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion
HOME
About Us
Our Business
Newsroom
Our Investments